Yes, you can increase venlafaxine from 75 mg in a patient with breakthrough symptoms
The dose can and should be increased by 75 mg increments at intervals of no less than 4 days, with a target therapeutic range of 150-225 mg/day for most patients with depression. 1
Dosing Algorithm
Your patient is currently on 75 mg daily, which is the starting dose, not a therapeutic dose. The FDA-approved dosing schedule is clear 1:
- Current dose: 75 mg/day (starting dose)
- First increase: 150 mg/day (can increase after 4 days minimum)
- Target therapeutic range: 150-225 mg/day
- Maximum dose: 375 mg/day (for severely depressed patients)
Why This Matters for Efficacy
Venlafaxine has a dose-dependent dual mechanism that makes dose escalation particularly important 2:
- At 75 mg/day: Predominantly serotonergic activity (like an SSRI)
- At 150-225 mg/day: Dual serotonin AND norepinephrine reuptake inhibition
- Efficacious dosage typically requires 2-4 weeks to titrate to 150-225 mg/day 2
The evidence shows that flexible dosing up to 150 mg provides superior efficacy compared to fixed 75 mg dosing 3. Multiple studies demonstrate that venlafaxine at higher doses (150-225 mg/day) shows significantly better response rates than lower doses 4, 5.
Practical Titration Strategy
Increase by 75 mg every 4-7 days as tolerated:
- Week 1-2: 75 mg/day (current dose - subtherapeutic)
- Week 2-3: 150 mg/day (minimum therapeutic dose)
- Week 3-4+: 225 mg/day if needed (optimal for many patients)
Important Safety Considerations
Monitor for these dose-dependent adverse effects:
- Blood pressure elevation: More common at doses >225 mg/day, but monitor at all doses 2, 6
- Cardiac conduction abnormalities: Rare but reported; use caution in cardiac disease 2
- Nausea: Most common in first 2 weeks, typically transient 7
- Discontinuation syndrome: Taper slowly when stopping (not relevant for dose increases) 2
Check blood pressure and pulse at each dose increase, especially when exceeding 150 mg/day 6.
Duration of Adequate Trial
Before declaring treatment failure, ensure an adequate trial of 4-6 weeks at the target dose of 150-225 mg/day 2. The patient has not yet received a therapeutic trial if they've only been on 75 mg.
When to Consider Higher Doses
If breakthrough symptoms persist at 225 mg/day after 4-6 weeks, doses up to 375 mg/day may be used in divided doses, particularly for more severely depressed patients 1. However, most outpatients respond adequately to 150-225 mg/day 1.
Therapeutic Drug Monitoring Consideration
Recent evidence suggests an optimal therapeutic reference range of 140-600 ng/mL for the active moiety (venlafaxine + O-desmethylvenlafaxine) 8. If the patient remains non-responsive despite dose increases, consider TDM to ensure adequate drug levels, as CYP2D6 genetic variability can significantly affect metabolism 9, 10.